Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Mint Reports Sudarshan Pharma Industries Limited Shares Fell to ₹34.65
Sudarshan Pharma Industries Limited's September-quarter filing showed growth in standalone revenue and profit, while Mint reported an Oct. 30 share decline that put analysts' price levels in focus. The company's board approved unaudited standalone…
Regeneron Pharma 3Q Sales Climb on Dupixent Growth
The drugmaker said Friday third-quarter revenue climbed 36% to $5.12 billion. Analysts polled by FactSet expected $4.56 billion. The growth was boosted by higher sales of Dupixent, which is approved for a range of conditions that include asthma and…
A pharma giant is moving past one patent cliff - but another is already looming
Novartis CEO Vas Narasimhan told CNBC on Tuesday that its drug remibrutinib could become 'one of our largest medicines in history.' But analysts slashed the peak sales forecast for the drug after a late-stage clinical trial for patients with…
BridgeBio Pharma: Q3 Earnings Snapshot
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $56.7 million in its third quarter. The Palo Alto, California-based company said it had a loss of 42 cents per share. The…
The Economic Times Reports Sun Pharma Above Its 20-day Average
The Economic Times reported Sun Pharmaceutical Industries Limited (Sun Pharma) shares above a reported 20-day simple moving average in early trading Oct. 30, the date set for a board meeting to consider and approve results. In its 11:46:26 p.m. ET…
Sun Pharma Q2 profit plunges 36% on exceptional charges despite revenue growth
Updated - October 30, 2026 09:51 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers Sun Pharmaceutical Industries reported a 36.4% year-on-year (YoY) decline in…
Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong
Oct 30 (Reuters) – India's Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, as a one-time charge largely tied to its planned acquisition of Organon weighed, though demand for specialty…
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
Indian drug regulators ordered Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding failure in its quality management system, documents reviewed by…
Exclusive-India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
HYDERABAD, Oct 30 (Reuters) – Indian drug regulators ordered Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding failure in its quality management system…
Flu's Back Way Sooner Than Normal. Here's What to Know.
A mutated strain of influenza is helping fuel an early start to the flu season, prompting experts to urge Americans to get their shots ASAP. Positive flu tests for this time of year have hit highs not seen in a decade, according to Centers for…
Nifty reclaims 23,000 to end October on a positive note; IT and Pharma lead, midcaps bleed
Within the Nifty 500 universe, only 108 stocks advanced, and both the Nifty Midcap 100 and Nifty Smallcap 100 ended in the red, falling 0.93 per cent and 1.85 per cent respectively. India VIX climbed around 3 per cent to 15.6. IT, healthcare and…
Sun Pharma taking remedial action, following voluntary withdrawal of 11 eye drops: Management
Sun Pharmaceutical Industries Ltd is taking remedial action, following the voluntarily recall of 11 eye drops from the marketplace, Kirti Ganorkar, Sun Managing Director told analysts at an interaction after the company announced its financial…
Cancer drug prices: Experts seek use of compulsory licensing, tighter checks on pharma pricing
The call comes amid concerns that the NPPA's 30 per cent trade-margin cap has had an uneven impact on cancer drug prices. While several generic and biosimilar brands have seen substantial reductions, many expensive originator and single-source…
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Target Cut by TD Cowen
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price objective lowered by analysts at TD Cowen from $110.00 to $100.00 in a report issued on Friday, Benzinga reports. The firm presently has a 'buy' rating on the stock. TD Cowen 's target…
Stock market today: Sensex, Nifty extend gains for second day as IT, pharma stocks lead rally
Indian equity benchmarks closed in positive territory for the second straight session on Friday, driven by buying in IT and pharma counters, while broader markets remained under pressure. The Sensex advanced 308.49 points, or 0.42 per cent, to…
Receive a Daily briefing on Pharma Industry News
Get Started